VIOPLEX-T

This brand name is authorized in Cyprus, Hong Kong, Malta

Active ingredients

The drug VIOPLEX-T contains a combination of these active pharmaceutical ingredients (APIs):

1 Neomycin UNII I16QD7X297 - NEOMYCIN

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code. Read about Neomycin

2 Bacitracin UNII 58H6RWO52I - BACITRACIN

Read about Bacitracin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D06AX04	Neomycin	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06A Antibiotics for topical use → D06AX Other antibiotics for topical use
Discover more medicines within D06AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 65302
Country: MT	Medicines Authority	Identifier(s): AA1227/00201